Visiting Dana-Farber? See our prescreening and mask requirements.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Dr. Amar Kelkar is a Stem Cell Transplantation Physician at the Dana-Farber Cancer Institute and an Instructor in Medicine at Harvard Medical School. His is a member of the Abel Laboratory with research interests are in hematology, care delivery, cost-effectiveness, medical ethics, and health policy. He is also completing a Master of Public Health degree at the Harvard T.H. Chan School of Public Health. His background is in molecular biology and genetics with a degree from Cornell University in Biological Sciences, where he worked for 3 years as a member of the Andrew Clark Laboratory focused on population genetics. He completed postgraduate medical training at the University of Illinois College of Medicine at Peoria, the University of Florida College of Medicine, and the Dana-Farber Cancer Institute. He has interests in health policy and medical advocacy and serves on the American Society of Hematology Committee on Practice and Subcommittee on Reimbursement, the American Society for Transplantation and Cellular Therapy Value and Health Economics Special Interest Group, and the Massachusetts Medical Society (MMS) Committee on Publications that oversees the NEJM Group. He previously served on the MMS Board of Trustees, the American Medical Association Council on Legislation.
Dana-Farber Cancer Institute450 Brookline AveBoston, MA 02215Get Directions